<DOC>
	<DOCNO>NCT01294839</DOCNO>
	<brief_summary>This prospective , randomize , double blind , multi-center , control study evaluate clinical impact 18 month DDD implantation alternative pace site ( RVOTs RVA ) different conduction path ( RVOTs AV node ) cardiac dysfunction prevention .</brief_summary>
	<brief_title>Right Ventricular Outflow Tract Study</brief_title>
	<detailed_description>Ventricular pace unavoidable many patient unreliable absent AV conduction , permanent AF . In recognition need , interest focus alternative site ( ) ventricular pace maximize pump function . These site include RV septum , His bundle , various LV site , combination LV RV ( biventricular [ BiV ] ) . The RV outflow tract septum ( RVOTs ) seem promising site within RV . However , small enrollment inconsistent experimental method hinder interpretation study . Locations alternative pace site clearly specify , largely topographic , lacked consistent anatomic designation . And , prospective , double-blind randomize , multi-center clinical trial design test whether RVOTs pace superior right ventricular apical pacing preserving leave ventricular systolic function avoid adverse leave ventricular remodel patient normal leave ventricular ejection fraction , ventricular synchrony standard indication pace ( sinus node dysfunction ) China . There also prospective , double-blind randomize , multi-center clinical trial design test whether RVOTs pace inferior AAIR pace preserve leave ventricular systolic function avoid adverse leave ventricular remodel patient normal leave ventricular ejection fraction , ventricular synchrony sinus node dysfunction world . So SJM China sponsor prospective , randomize , double blind , multi-center , control study evaluate clinical impact 18 month DDD implantation alternative pace site ( RVOTs RVA ) different conduction path ( RVOTs AV node ) cardiac dysfunction prevention .</detailed_description>
	<mesh_term>Sick Sinus Syndrome</mesh_term>
	<criteria>Patients sinusnode dysfunction meet pace indication Patients LVEFâ‰¥60 % ventricular synchrony . Patients sign write informed consent study Patients endure require follow Patients atrial fibrillation Patients atrialventricular block Patients LBBB Patients significant valvular disease Patients severe hematopathy severe renal inadequacy Patients life expectancy &lt; 1.5 year Patients period pregnant lactation Patients young 18 year old Patients ongoing device agent study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>sinus-node dysfunction</keyword>
	<keyword>RVOTs pacing</keyword>
	<keyword>RVA pacing</keyword>
</DOC>